Cargando…
A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infection
Intestinal colonization with pathogens and antimicrobial-resistant organisms (AROs) is associated with increased risk of infection. Fecal microbiota transplant (FMT) has successfully been used to cure recurrent Clostridioides difficile infection (rCDI) and to decolonize intestinal AROs. However, FMT...
Autores principales: | Rooney, Ashley M., Cochrane, Kyla, Fedsin, Stephanie, Yao, Samantha, Anwer, Shaista, Dehmiwal, Satyender, Hota, Susy, Poutanen, Susan, Allen-Vercoe, Emma, Coburn, Bryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506460/ https://www.ncbi.nlm.nih.gov/pubmed/37404011 http://dx.doi.org/10.1128/mbio.03482-22 |
Ejemplares similares
-
Diaminopimelic Acid Metabolism by Pseudomonadota in the Ocean
por: Zheng, Li-Yuan, et al.
Publicado: (2022) -
Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
por: Hota, Susy S, et al.
Publicado: (2018) -
Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
por: Li, Xianping, et al.
Publicado: (2019) -
Pseudomonadota in the oral cavity: a glimpse into the environment-human nexus
por: Leão, Inês, et al.
Publicado: (2022) -
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile
por: Carlucci, Christian, et al.
Publicado: (2019)